Life sciences industries including biotechnology,pharmaceuticals, chemicals and medical devices are not only facedwith the risks of globalization, supply chain liability andlitigious operating environments, but they are also exposed to cashflow issues as a result of falling volumes, while trying tomitigate against emerging risks like healthcare reform andintellectual property theft.
|Willis has established a life sciences practice to respond tothese new risks and the changing business model of theindustry.
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
- Educational webcasts, resources from industry leaders, and informative newsletters.
- Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
